Bowlers' grip.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9565303)

Published in Contact Dermatitis on April 01, 1998

Authors

C C Lyon1, J O'Driscoll, U Erikstam, M Bruze, M H Beck

Author Affiliations

1: Dermatology Centre, University of Manchester Medical School, Hope Hospital, Salford, UK.

Articles by these authors

Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health (2001) 2.20

Contact allergy to gold in patients with gold-plated intracoronary stents. Contact Dermatitis (2005) 2.04

Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01

Potent topical steroid obtained from a Chinese herbalist. Br J Dermatol (1992) 1.87

The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol (2000) 1.69

Skin disorders in amputees. J Am Acad Dermatol (2000) 1.65

Clinically relevant contact allergy to formaldehyde may be missed by testing with formaldehyde 1·0%. Br J Dermatol (2011) 1.64

Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis (2002) 1.63

Monitoring the European standard series in 10 centres 1996-2000. Contact Dermatitis (2005) 1.41

Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate? Contact Dermatitis (1999) 1.39

Patch testing with low concentrations of budesonide detects contact allergy. Contact Dermatitis (1997) 1.39

Stability of fragrance patch test preparations applied in test chambers. Br J Dermatol (2012) 1.38

An audit to identify the optimum referral rate to a contact dermatitis investigation unit. Br J Dermatol (1999) 1.38

Variation in allergen content over time of acrylates/methacrylates in patch test preparations. Br J Dermatol (2011) 1.36

Secondary syphilis with framboesiform facial lesions: a case report. Br J Vener Dis (1981) 1.24

Extensive nevus comedonicus. Arch Dermatol (1980) 1.16

Surveillance of occupational skin disease: EPIDERM and OPRA. Br J Dermatol (2000) 1.15

Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA. Occup Med (Lond) (2000) 1.15

Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol (2000) 1.13

Infectious complications of blood transfusion. BMJ (1990) 1.04

Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat (2001) 1.03

Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol (2003) 1.00

Urticaria successfully treated by desensitization with grass pollen extract. Br J Dermatol (1989) 1.00

Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol (2008) 1.00

Antinuclear antibodies during Puva therapy. Acta Derm Venereol (1979) 1.00

Type I allergic reaction to hyaluronidase during ophthalmic surgery. Contact Dermatitis (2001) 0.99

Allergic contact dermatitis to epichlorhydrin in a solvent cement. Contact Dermatitis (1983) 0.96

The flare-up reactions after systemic provocation in contact allergy to nickel and gold. Contact Dermatitis (1999) 0.94

Progesterone-induced urticaria--need it be autoimmune? Br J Dermatol (1995) 0.93

Allergic contact dermatitis from diphenylthiourea in Vulkan heat retainers. Contact Dermatitis (1990) 0.92

Phaeohyphomycosis caused by Exophiala salmonis. Br J Dermatol (2006) 0.92

Patch testing to detect corticosteroid allergy: is it adequate? Contact Dermatitis (1997) 0.91

Screening for corticosteroid contact hypersensitivity. Contact Dermatitis (1995) 0.91

Further important sensitizers in patients sensitive to fragrances. Contact Dermatitis (2002) 0.88

Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo. Contact Dermatitis (1998) 0.86

Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG. Contact Dermatitis (2000) 0.86

Biomonitoring of 4,4'-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans. Int Arch Occup Environ Health (1995) 0.86

Salmonella osteomyelitis in aplastic anaemia after antilymphocytic globulin and steroid treatment. J Clin Pathol (1992) 0.85

Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J (Clin Res Ed) (1983) 0.84

Contact allergy to textile dyes in southern Sweden. Contact Dermatitis (2006) 0.84

Allergic contact dermatitis from Machaerium scleroxylum Tul. (Pao ferro) in a joinery shop. Clin Exp Dermatol (1984) 0.84

Ammonium persulphate sensitivity in hairdressers. Contact Dermatitis (1985) 0.83

The significance of previous contact dermatitis for elicitation of contact allergy to nickel. Acta Derm Venereol (1998) 0.83

A safety assessment of branched chain saturated alcohols when used as fragrance ingredients. Food Chem Toxicol (2010) 0.83

Corticosteroid contact hypersensitivity: what vehicle and concentration? Contact Dermatitis (1996) 0.82

Mechanism of the antigen formation of carvone and related alpha, beta-unsaturated ketones. Contact Dermatitis (2001) 0.82

Human amnion in the management of chronic ulceration of the lower limb: a clinico-pathologic study. Angiology (1983) 0.82

Allergic contact dermatitis from latex rubber. Br J Dermatol (1996) 0.82

Contact dermatitis from electrocardiograph-monitoring electrodes: role of p-tert-butylphenol-formaldehyde resin. Contact Dermatitis (2003) 0.81

Epidemiological survey of standard series patch test results and observations on day 2 and day 4 readings. Contact Dermatitis (1991) 0.81

Occupational allergic contact dermatitis from triphenyl phosphite. Contact Dermatitis (1989) 0.81

Allergic contact dermatitis from an anthraquinone derivative in a chemical plant. Contact Dermatitis (1994) 0.81

Spa pool dermatitis. Contact Dermatitis (1995) 0.81

Individual variation in nickel patch test reactivity. Am J Contact Dermat (1999) 0.81

The effects of concurrent atorvastatin therapy on the pharmacokinetics of intravenous midazolam. Anaesthesia (2003) 0.80

Occupational allergic contact dermatitis caused by isocyanates. Contact Dermatitis (2002) 0.80

Degradation of triglycidyl isocyanurate as a cause of false-negative patch test reaction. Contact Dermatitis (2001) 0.80

Severe erythema multiforme complicated by fatal gastrointestinal involvement following co-trimoxazole therapy. Clin Exp Dermatol (1979) 0.80

Incidence by occupation and industry of work-related skin diseases in the United Kingdom, 1996-2001. Occup Med (Lond) (2006) 0.80

An epidemic of occupational contact dermatitis from an immersion oil for microscopy in laboratory personnel. Contact Dermatitis (1999) 0.80

Contact dermatitis from 2-n-octyl-4-isothiazolin-3-one in a PhD student. Contact Dermatitis (2004) 0.80

A toxicologic and dermatologic assessment of cinnamyl phenylpropyl materials when used as fragrance ingredients. Food Chem Toxicol (2011) 0.80

Allergic contact dermatitis to crystal violet lactone [corrected] in carbonless copy paper. Contact Dermatitis (1987) 0.80

Antinuclear antibodies in mice induced by long wave ultraviolet radiation (UVA). Acta Derm Venereol (1985) 0.79

The lipophilic hapten parthenolide induces interferon-gamma and interleukin-13 production by peripheral blood-derived CD8+ T cells from contact allergic subjects in vitro. Br J Dermatol (2007) 0.79

Citral a fragrance allergen and irritant. Contact Dermatitis (2003) 0.79

Toxicodendron dermatitis in the UK. Int J Dermatol (2006) 0.79

A toxicological and dermatological assessment of alkyl cyclic ketones when used as fragrance ingredients. RIFM Expert Panel. Food Chem Toxicol (2013) 0.79

Deodorants on the European market: quantitative chemical analysis of 21 fragrances. Contact Dermatitis (1998) 0.79

Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis. Contact Dermatitis (2000) 0.79

Intolerance and contact allergy to tar and dithranol in psoriasis. Contact Dermatitis (1994) 0.79

Cross-reactivity between nickel and palladium demonstrated by systemic administration of nickel. Contact Dermatitis (2005) 0.79

The significance of previous allergic contact dermatitis for elicitation of delayed hypersensitivity to nickel. Contact Dermatitis (1997) 0.79

Occupational allergic contact dermatitis from epoxy resins based on bisphenol F. Contact Dermatitis (1999) 0.79

Epoxy-based production of wind turbine rotor blades: occupational dermatoses. Contact Dermatitis (2004) 0.78

Immune responses to hair dyes containing toluene-2,5-diamine. Br J Dermatol (2014) 0.78

High frequency of contact allergy to gold sodium thiosulfate. An indication of gold allergy? Contact Dermatitis (1994) 0.78

Flare-up reactions after oral challenge with nickel in relation to challenge dose and intensity and time of previous patch test reactions. J Am Acad Dermatol (2001) 0.78

Maternal group B streptococcal meningitis in the postpartum period. J Obstet Gynaecol (2003) 0.78

Chromosome breakage induced in vivo by a carcinogenic hydrocarbon in bone marrow cells of the Chinese hamster. Hereditas (1969) 0.78

Lymphocyte transformation and thiuram sensitization. Contact Dermatitis (1991) 0.78

Occupational dermatoses in composite production. J Occup Environ Med (1999) 0.78

Contact sensitivity to octyldodecanol and trometamol in an anti-itch cream. Contact Dermatitis (2007) 0.78

The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol (2007) 0.78

Contact sensitivity to vanilla in a lip salve. Contact Dermatitis (1995) 0.78

Allergic contact dermatitis from ethylene thiourea. Contact Dermatitis (1983) 0.78

The significance of positive patch tests to 17-hydroxyprogesterone. Contact Dermatitis (1994) 0.78

Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus. Diabet Med (2000) 0.78

A toxicological and dermatological assessment of aryl alkyl alcohol simple acid ester derivatives when used as fragrance ingredients. Food Chem Toxicol (2012) 0.78

Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. Br Med J (Clin Res Ed) (1985) 0.78

In vivo testing of the protection of gloves against acrylates in dentin-bonding systems on patients with known contact allergy to acrylates. Contact Dermatitis (1999) 0.78

Fatal connective tissue disease with antinuclear antibodies following PUVA therapy. Acta Derm Venereol (1984) 0.78

Further important sensitizers in patients sensitive to fragrances. Contact Dermatitis (2002) 0.78

Type IV hypersensitivity reactions to natural rubber latex: results of a multicentre study. Br J Dermatol (2002) 0.78

How to do sensitization tests in guinea pigs. Contact Dermatitis (1994) 0.77

Late patch test reaction to Disperse Orange 1 not related to active sensitization. Contact Dermatitis (2010) 0.77

Clinical reactions to systemic provocation with gold sodium thiomalate in patients with contact allergy to gold. Br J Dermatol (1996) 0.77

Morphology of endogenous flare-up reactions in contact allergy to gold. Acta Derm Venereol (1997) 0.77